[Antiviral therapy in a patient with chronic hepatitis C, metabolic syndrome and interferon-induced depression].

Abstract

A case of metabolic syndrome is reported in which its elimination before the onset of antiviral treatment of chronic hepatitis A and drug therapy of subsequent depression promoted successful outcome with a stable virological response. Modern approaches are discussed to enhancing efficiency of antiviral therapy by active correction of factors responsible for poor results of the treatment and its undesirable consequences.

• Authors: Zh Zh Baĭzhanova, T M Ignatova, M A Kinkul'kina
• Journal: Klinicheskaia meditsina (Klin Med (Mosk)) Vol. 88 Issue 6 Pg. 65-7 ( 2010) ISSN: 0023-2149 [Print] Russia (Federation)
• PMID: 21395034 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antidepressive Agents, Tricyclic
• Antiviral Agents
• Interferon alpha-2
• Interferon-alpha
• Recombinant Proteins
• Thiazepines
• tianeptine
• Polyethylene Glycols
• peginterferon alfa-2b

Topics

• Adult
• Antidepressive Agents, Tricyclic (therapeutic use)
• Antiviral Agents (adverse effects, therapeutic use)
• Depression (chemically induced, complications, drug therapy)
• Drug Therapy, Combination
• Exercise Therapy (methods)
• Female
• Follow-Up Studies
• Hepatitis C, Chronic (complications, drug therapy)
• Humans
• Interferon alpha-2
• Interferon-alpha (adverse effects, therapeutic use)
• Metabolic Syndrome (complications, therapy)
• Polyethylene Glycols (adverse effects, therapeutic use)
• Recombinant Proteins
• Thiazepines (therapeutic use)